Medicinova (MNOV) Net Equity Issued and Repurchased (2010 - 2020)
Medicinova (MNOV) posted quarterly Net Equity Issued and Repurchased of $291919.0 for Q4 2020, down 94.04% quarter-over-quarter from $4.9 million in Q3 2020.
Medicinova (MNOV) Net Equity Issued and Repurchased (2010 - 2020) Analysis & Trends
Medicinova (MNOV) has reported Net Equity Issued and Repurchased for 9 consecutive years, with $291919.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Net Equity Issued and Repurchased changed N/A year-over-year to $291919.0; the TTM figure through Dec 2020 stood at $9.5 million (changed N/A YoY), while the FY2025 annual figure was $200000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased fell to $291919.0 in Q4 2020 per MNOV's latest filing, from $4.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $4.9 million in Q3 2020 and bottomed at $24800.0 in Q1 2017.
- Historically, Net Equity Issued and Repurchased has averaged $1.4 million across 3 years, with a median of $291919.0 in 2020.
- Annual changes were most pronounced in 2016 — Net Equity Issued and Repurchased sank 91.4% — and 2017, when it surged 2114.2%.
- Medicinova's Net Equity Issued and Repurchased stood at $176271.0 in 2016, then soared by 2114.2% to $3.9 million in 2017, then sank by 92.52% to $291919.0 in 2020.
- Business Quant data shows MNOV's Net Equity Issued and Repurchased at $291919.0 in Q4 2020, $4.9 million in Q3 2020, and $400000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 291,919.00 |
| Dec 31, 2020 | 291,919.00 |
| Sep 30, 2020 | 4.90 Mn |
| Sep 30, 2020 | 4.90 Mn |
| Mar 31, 2020 | 400,000.00 |
| Mar 31, 2020 | 400,000.00 |
| Dec 31, 2017 | 3.90 Mn |
| Dec 31, 2017 | 3.90 Mn |
| Jun 30, 2017 | 2.78 Mn |
| Jun 30, 2017 | 2.78 Mn |
| Mar 31, 2017 | 24,800.00 |
| Mar 31, 2017 | 24,800.00 |
| Dec 31, 2016 | 176,271.00 |
| Dec 31, 2016 | 176,271.00 |
| Sep 30, 2016 | 37,806.00 |
| Sep 30, 2016 | 37,806.00 |
| Mar 31, 2016 | 49,923.00 |
| Mar 31, 2016 | 49,923.00 |
| Dec 31, 2015 | 810,092.00 |
| Dec 31, 2015 | 810,092.00 |